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‘‘Black Holes’’ and the Ocular Glymphatic
System: Author Response to ‘‘The Glymphatic
System: A New Player in Ocular Diseases?’’
In early June 2015, IOVS published our novel hypothesis of the
existence of an ‘‘ocular glymphatic system.’’1 At the time, it had
some resemblance to cosmological predictions of the existence
of ‘‘black holes’’: it was based primarily on logic, in our case the
embryological, anatomical, and physiological relationships
between the eye and the brain, and indirect observations.
Direct visualization was lacking. We argued that, assuming that
Iliff and colleagues2 were correct in the observations of a
paravascular transport system within the central nervous
system (CNS), then it seemed very likely that there would be
a similar system within the eye. Various ‘‘thought experiments’’
showed how the existence of this additional fluid transport
system could provide plausible explanations for a wide variety
of poorly understood phenomena within the eye. Key examples
from the major blinding diseases included the extent to which
the ocular glymphatic system may contribute to the following:
the reduced clearance of waste metabolites and toxins seen
over time with implications for the development of age-related
macular degeneration and possibly some hereditary dystro-
phies; the variable sensitivity of the optic disc to the level of
IOP at which glaucomatous neuropathy occurs, contributing to
a number of different types of glaucoma; and the tolerance of
the retina to withstand ischemic insults including whether they
develop macular edema and its distribution and severity in
conditions such as diabetes and retinal vascular occlusion. We
also had a particular interest in two other areas: whether an
ocular glymphatic system might explain the variable tolerance
of optic discs to different levels of raised intracranial pressure in
terms of disc swelling and optic nerve function, as seen in
idiopathic intracranial hypertension and other forms of
papilledema, and the direction and pattern of spread of certain
retinal infective or inflammatory processes. It was in the latter
context that we looked for the first direct evidence of the
ocular glymphatic system, speculating that some of the
ultrastructural changes highlighted in cases of retinal vasculitis
imaged by adaptive optics might represent paravascular flow
(Errera M-H, et al. IOVS 2015;56:ARVO E-Abstract 5303).
We were therefore delighted to see the publication of the
work by Wostyn et al,3–6 which they have appropriately
highlighted here and which provides independent new
evidence for the existence of the ocular glymphatic system.
They have elegantly described how the ocular glymphatic
system might contribute to the development of glaucoma,
making the same argument that we had done previously and
providing new direct and indirect evidence4; they also have
highlighted how this may be affected by cerebrospinal fluid
(CSF) pressure and how in turn it may affect the balance of
production and clearance of neurotoxins, drawing an interest-
ing link between the development of glaucoma and Alzheimer’s
disease.3,5,6 We suspect that this is just the start, and that there
will be a rapid proliferation of work across a range of ocular
diseases. This is likely to be initially focused around the
aquaporin-4 channel,7 but then extended to encompass the
broader picture of paravascular flow and the glymphatic system,
and their relevance to a wide range of ophthalmic conditions.1
It might be surprising that an entirely new transport system
could exist in the eye without being noticed until now. After all,
the systemic lymphatic system was described more than 350
years ago. But, to return to our previous analogy with black
holes, these structures can be very difficult to visualize. The role
of a conventional lymphatic system in the eye is itself an emerg-
ing field, and it was only in 2015 that the ‘‘missing link’’ of a true
lymphatic system within the brain was established.8 In that
important article, Louveau et al.8 noted its relevance to the
glymphatic system, stating that, ‘‘The newly discovered menin-
geal lymphatics are a novel path for CSF drainage and represent
a more conventional path for immune cells to egress the CNS.
Our findings may represent the second step in the drainage of
the interstitial fluid from the brain parenchyma into the
periphery after it has been drained into the CSF through the
recently discovered glymphatic system.’’8 We believe that the
next 10 years will see a major paradigm shift in our understand-
ing of transport of fluid, solutes, and cells through the eye, with
a new understanding of the relationship of the arteriovenous
system and its integration to both an ocular glymphatic system
and lymphatic system. We look forward to seeing how advances
in imaging and functional analysis reveal the physiology and
pathophysiology of these systems, but even more importantly to
see if this process can be modified, providing an entirely new
target for treatment for many blinding diseases.
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